Publisher John Wiley & Sons, Inc., The American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) have announced their partnership to publish the new open access, peer-reviewed journal, Pharmacology Research & Perspectives, which will open for submissions in April 2013.
Pharmacology Research & Perspectives (PR&P) will publish original research, reviews and perspectives in all areas of preclinical and clinical pharmacology, therapeutics, education and related research areas. The journal will serve as the first fully open access journal for ASPET and BPS, and joins their combined portfolio of prestigious peer-reviewed subscription-based scientific journals, such as the Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Molecular Pharmacology, British Journal of Pharmacology, and British Journal of Clinical Pharmacology.
Dr. Michael J. Curtis will serve as the Editor-in-Chief of the journal. Dr. Curtis has extensive editorial experience, serving as Editor-in-Chief of the Journal of Pharmacological and Toxicological Methods and Reviews Editor of British Journal of Pharmacology, among other positions.
All articles in PR&P will be published as fully open access under a Creative Commons License on Wiley Online Library and deposited in PubMed Central immediately upon publication. A publication fee will be payable by authors on acceptance of their articles. Authors affiliated with, or funded by, an organisation that has a Wiley Open Access Account can publish without directly paying any publication charges.
The journal expects to publish its first issue in autumn 2013.
